Tilray Brands (TLRY) Other Non Operating Income (2017 - 2026)
Tilray Brands (TLRY) posted Other Non Operating Income of -$20000.0 for Q1 2026, up 98.79% on a QoQ basis from -$1.6 million in Q4 2025, and down 100.83% year-over-year from $2.4 million in Q1 2025.
Tilray Brands (TLRY) Other Non Operating Income (2017 - 2026) Analysis & Trends
Tilray Brands' Other Non Operating Income history runs 10 years deep, the most recent figure standing at -$20000.0 for Q1 2026.
- Quarterly Other Non Operating Income fell 100.83% year-over-year to -$20000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $1.4 million (up 105.43% YoY) and the FY2025 annual result came in at -$41.7 million, down 10.14% from the prior year.
- Other Non Operating Income was -$20000.0 for Q1 2026 at Tilray Brands, up from -$1.6 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $71.0 million in Q1 2022 and bottomed at -$105.0 million in Q2 2022.
- A 5-year average of -$5.1 million and a median of -$184000.0 in 2022 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income surged 38498.38% — and 2025, when it plunged 462.8%.
- Tilray Brands' Other Non Operating Income stood at $907000.0 in 2022, then plunged by 206.62% to -$967000.0 in 2023, then surged by 69.7% to -$293000.0 in 2024, then plunged by 462.8% to -$1.6 million in 2025, then jumped by 98.79% to -$20000.0 in 2026.
- Business Quant data shows TLRY's Other Non Operating Income at -$20000.0 in Q1 2026, -$1.6 million in Q4 2025, and $543000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -20,000.00 |
| Nov 30, 2025 | -1.65 Mn |
| Aug 31, 2025 | 543,000.00 |
| May 31, 2025 | 2.53 Mn |
| Feb 28, 2025 | 2.40 Mn |
| Nov 30, 2024 | -293,000.00 |
| Aug 31, 2024 | 11.88 Mn |
| May 31, 2024 | -39.78 Mn |
| Feb 29, 2024 | -3.30 Mn |
| Nov 30, 2023 | -967,000.00 |
| May 31, 2023 | -18.31 Mn |
| Feb 28, 2023 | -1.37 Mn |
| Nov 30, 2022 | 907,000.00 |
| Aug 31, 2022 | -75,000.00 |
| May 31, 2022 | -105.01 Mn |
| Feb 28, 2022 | 71.04 Mn |
| Nov 30, 2021 | 65.60 Mn |
| Aug 31, 2021 | 191,000.00 |
| May 31, 2021 | -24.39 Mn |
| Feb 28, 2021 | -185,000.00 |